Home/Filings/4/0001193125-26-016451
4//SEC Filing

Forbes William P 4

Accession 0001193125-26-016451

CIK 0000818033other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 3:00 PM ET

Size

7.0 KB

Accession

0001193125-26-016451

Insider Transaction Report

Form 4
Period: 2026-01-19
Forbes William P
EVP, Chief Development Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-19+3,875170,078 total
  • Exercise/Conversion

    Restricted Stock Units

    [F2]
    2026-01-193,87530,994 total
    Exercise: $0.00Common Stock (3,875 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).
Signature
/s/ Kathryn Lester Attorney-in-Fact for William P. Forbes|2026-01-20

Documents

1 file

Issuer

HERON THERAPEUTICS, INC. /DE/

CIK 0000818033

Entity typeother

Related Parties

1
  • filerCIK 0001314760

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 3:00 PM ET
Size
7.0 KB